Autopsy report · NCT03966885
Zambia Common Elements Treatment Approach Pilot Study
Cause of deathStaffing, sites or logistics
“COVID-19 precluded the study team from being able to complete all follow-up assessments.The study was halted on March 17, 2020 and did not resume.”
Life of this trial
- Registered 1 month before it started.
- Ran for about 9 months before it stopped.
- 160 participants enrolled.
- Results were posted on the registry 2 years 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Columbia University
- Sponsor type
- University, hospital or other
- Conditions
- Alcohol Use Disorder; Depression; Post-traumatic Stress Disorder; HIV/AIDS; Substance Use Disorders
- Interventions
- Brief Intervention; Common Elements Treatment Approach (CETA)
- Participants
- 160
- Sites
- 1
- Countries
- Zambia
Trials that died the same way
- New Formulations of Propafenone to Treat Atrial Fibrillation
“Study halted/terminated prematurely due to COVID.” - Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)
“Study halted prematurely due COVID-19 pandemic and did not resume; participants are no longer being examined or receiving intervention.” - Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia
“Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. COVID Complications.” - FMT for MDRO Colonization After Infection in Renal Transplant Recipients
“This study was paused and was not resumed due to the COVID-19 pandemic.” - RAman For Thyroid cancER
“Covid19 halted study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.